Mirror Syndrome Associated with Fetal Cardiac Anomaly: A Case Report

Authors

  • Prapat Wanitpongpan Department of Obstetrics and Gynecology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700
  • Kusol Russameecharoen Department of Obstetrics and Gynaecology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700
  • Tuenjai Chuangsuwanich Department of Pathology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700
  • Buraya Phattanachindakun Department of Obstetrics and Gynaecology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700

Keywords:

AVSD; Ballantyne syndrome; fetal hydrops; mirror syndrome

Abstract

A rare mirror syndrome (Ballantyne syndrome) was seen in a woman who carried a hydropic fetus caused by fetal atrio-ventricular septal defect (AVSD). Diagnosis was made with confidence after ruling out cardiogenic pulmonary edema and preeclampsia. Placental pathology demonstrated multifocal villous edema and accelerated maturation of trophoblasts which may
support the earlier reports about potential etiologic roles of the placenta to trigger the disease.

References

1. Vidaeff AC, Pschirrer ER, Mastrobattista JM, Gilstrap LC 3rd, Ramin SM. Mirror syndrome: A case report. J Reprod Med. 2002 Sep;47(9):770-4.
2. Deurloo K, Devlieger R, Oepkes D. Maternal hydrops syndrome following successful treatment of fetal hydrops by shunting of bilateral hydrothorax.
Prenat Diagn. 2003 Nov;23(11):944-5.
3. Pirhonen JP, Hartgill TW. Spontaneous reversal of mirror syndrome in a twin pregnancy after a single fetal death. Eur J Obstet Gynecol Reprod
Biol. 2004 Sep 10;116(1):106-7.
4. Goeden AM, Worthington D. Spontaneous resolution of mirror syndrome. Obstet Gynecol. 2005 Nov;106(5 Pt 2):1183-6.
5. Brochot C, Collinet P, Provost N, Subtil D. Mirror syndrome due to parvovirus B19 hydrops complicated by severe maternal pulmonary effusion.
Prenat Diagn. 2006 Feb;26(2):179-80.
6. Espinoza J, Romero R, Nien JK, Kusanovic JP, Richani K, Gomez R, et al. A role of the anti-angiogenic factors sVEGFR-1 in the “mirror syndrome”
(Ballantyne’s syndrome). J Matern Fetal Neonatal Med. 2006 Oct;19(10):607-13.
7. Leung WC, Lam HS, Tang MH, Lao TT. Biochemical hypothyroidism - a new finding in mirror syndrome? Eur J Obstet Gynecol Reprod Biol.
2006 Apr 1;125(2):269-71.
8. Mizrahi-Arnaud A, Haug LW, Marshall A, Silva V. Maternal Mirror syndrome after in utero aortic valve dilation, a case report. Fetal Diagn
Ther. 2006;21(5):439-43.
9. Livingston JC, Malik KM, Crombleholme TM, Lim FY, Sibai BM. Mirror syndrome: a novel approach to therapy with fetal peritoneal-amniotic
shunt. Obstet Gynecol. 2007 Aug;110(2 Pt 2):540-3.
10. Valsky DV, Daum H, Yagel S. Reversal of mirror syndrome after prenatal treatment of Diamond-Blackfan anemia. Prenat Diagn. 2007 Dec;27(12):
1161-4.
11. Duthie SJ, Walkinshaw SA. Parvovirus associated fetal hydrops: reversal of pregnancy induced proteinuric hypertension by in utero transfusion.
Br J Obstet Gynaecol. 1995 Dec;102(12):1011-3.
12. Heyborne KD, Chism DM. Reversal of Ballantyne syndrome by selective second-trimester fetal termination. J Reprod Med. 2000 Apr;45(4):360-2.
13. Midgley DY, Harding K. The Mirror syndrome. Eur J Obstet Gynecol Reprod Biol. 2000 Feb;88(2):201-2.
14. Allan LD. Atrioventricular septal defect in fetus. Am J Obstet Gynecol. 1999 Nov;181(5 Pt 1):1250-3.
15. Carbillon L, Oury JF, Guerin JM, Azancot A, Blot P. Clinical biological features of Ballantyne syndrome and the role of placental hydrops.
Obstet Gynecol Surv. 1997 May;52(5):310-4.

Downloads

Published

03-04-2020

How to Cite

Wanitpongpan, P. ., Russameecharoen, K. ., Chuangsuwanich, T. ., & Phattanachindakun, B. . (2020). Mirror Syndrome Associated with Fetal Cardiac Anomaly: A Case Report. Siriraj Medical Journal, 63(2), 58–59. Retrieved from https://he02.tci-thaijo.org/index.php/sirirajmedj/article/view/240908

Issue

Vol. 63 No. 2 (2011): March-April

Section

Case Report

License

Users are free to share, copy, and redistribute all articles published in the Siriraj Medical Journal (SMJ) in any medium or format as long as you follow the following terms:

  • Attribution — You must give appropriate credit, provide a link to the material, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the publisher endorses you or your use.
  • NonCommercial — You may not use the material for commercial purposes.
  • NoDerivatives — If you remix, transform, or build upon the material, you may not distribute the modified material.
  • No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.